NCT07379125 2026-01-30Therapeutic RSK1 Targeting in MyelofibrosisWashington University School of MedicinePhase 1 Not yet recruiting18 enrolled
NCT04709458 2022-05-03Safety and Early Efficacy Study of TBX-2400 in Patients With AML or MyelofibrosisTaiga Biotechnologies, Inc.Phase 1 Unknown10 enrolled